FDA Investigator Joseph R Haynes
Joseph R Haynes has inspections in 5 countries as of 03 Nov 2023. Joseph R Haynes has collaborated with a combinined 3187 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
65
Last Inspection Date:
03 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
Netherlands,
United Kingdom of Great Britain and Northern Ireland,
Germany
Co-Investigator(s):
Aaron W Pursley,
Alexandra A Carrico,
Alicia A Borg Borm,
Amina Bashir,
Andrea A Branche,
Andrea J Schmidt,
Andrew K Schaal,
Andrew T Todd,
Anthony R Petriella,
Antonio M Hampton,
Armando Morales,
Art O Czabaniuk,
Ashar P Parikh,
Baask,
Barbara A Rusin,
Barbara J Rincon,
Betty K Baxter,
Bevill,
Bleta Vuniqi,
Boun M Xiong,
Brian J Davis,
Brian M Campbell,
Brian P Putz,
Brian R Cronenwett,
Bruce,
Bruce E Taylor,
Byron Ho, DVM,
Byron S Beerbower,
Carla J Lundi,
Carol Mrivera Lopez, PhD,
Carr Sharpe,
Cathie S Marshall,
Chad W Rice,
Charles A Snipes, PhD,
Chase S Baldwin,
Christi L Bellmore,
Christine J Watts,
Christopher J Cruciotti,
Clinton R Vanblaricom,
Corey K Reno,
Crystal M Young Lewis,
Da Lin Yao, MD, PhD,
Daniel J Gorski,
Darrah,
David M Amy,
Davis,
Dawn C Olenjack,
Dennis R Downer,
Diane T Reindl,
Dina A Tallman,
Donald B Mckechnie,
Donald W Myrick,
Dongping Dai, PhD,
Donna K Speer,
Douglas J Scott,
Douglas W Gronski,
Downer,
Dr. Hansong Chen, PhD,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dwight D Ferguson,
Dylan C Grippi,
Dylan D Yao, MD, PhD,
Elizabeth J Rigoni,
Elizabeth L Holmes,
Emily J Orban,
Eric E Joneson,
Eric S Pittman,
Erica L Bakota,
Erin M Miller,
Frank L Cordova,
Frans E Mercado,
French,
Gajendiran Mahadevan, PhD,
Garciam,
Glasgow,
Gulshan R Anand,
Hartman,
Hassan Ali,
Heath W Cartwright,
Hokenson,
Ifueko Osemwota,
Ingrid A Zambrana,
Jacob A Clark,
James L Finn,
Jamie R Thompson,
Jankowski,
Jeannine K Wooten,
Jeffrey B Moody,
Jeffrey D Meng,
Jennifer R Johnson,
John A Gonzalez,
John N Woodall,
Johnson,
Johnsont,
Jonathan A Ferguson,
Jose Acruz Gonzalez,
Joseph M Willems,
Judy C Nepsa,
Julia A Avery,
Julia Ventura,
Julie N Vosilus,
Justin R Hays,
Kate L Allen,
Katharine Chan,
Katherine M Taylor,
Katherine Szestypalow,
Kathryn A Cutajar,
Kathryn A Guardiola,
Kathryn M Mogen,
Kawshalya Pathiraja,
Keith C Littrell,
Kellia N Hicks,
Kellie L Thommes, RN,
Kelvin X Sanders,
Kevin P Foley,
Kham Phommachanh,
Lam,
Ligia M Cline,
Ligia M Sanders,
Lisa J Joseph,
Lisa M Thursam,
Lopez,
Loretta J Jordan,
LTJG Aaron B Otis,
Margaret N Persich,
Mark G Peterson,
Marlon K Turner,
Marshall,
Martin R Vowell,
Matthew A Walburger,
Mei Chen Mu,
Melissa N Simanton,
Melissa N Wilson,
Melva J Palmer,
Merelynn Rhoten,
Michael D Garcia,
Michael F Skelly, PhD,
Michael L Chasey,
Michele L Forster, PhD,
Michelle D Motsinger,
Michelle L Jones,
Miguel A Martinez,
Mikhail V Ovanesov, PhD,
Misty D Harvey,
Myers,
Nancy A Bellamy,
Natalie A Mickelsen, DVM,
Nelson,
Nicholas E Boyd,
Niraj Mehta,
Orval D Mcintire,
Patricia A Maestas,
Patrick E Gainer,
Patrick J Campbell,
Paul E Frazier,
Philip J Boston,
Philip M Steele, PhD,
Rasha Bamieh,
Rebecca L Keller,
Rebecca L Mullikin,
Renick,
Robert J Waldorf,
Rodriguez,
Ryan J Benedict,
Samantha J Bradley,
Sean P Desbrow,
Shana L Williams,
Sonya M Lambkin,
Sripal R Mada, PhD,
Staci G Mcallister,
State Agency,
Steven M Galvez,
Steven P Allen,
Sullan,
Ted L Anderson,
Theresa L Stewart,
Thomas W Gordon,
Tonnie L Carter,
Tracey Asinjen Wiersma,
Tracey L Siebesma,
Tristian E Strait,
Twana R Chandler,
Victoria A Murray,
Walsworth,
Wendy M Stark,
William D Tingley,
William G Nelson,
Xikui Chen (nmi), PhD
Joseph R Haynes's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2022 | FDA 483 | Arrow Reliance Inc - Form 483, 2022-09-30 |
September, 2022 | FDA 483 Response | Arrow Reliance Inc - Form 483R, 2022-09-30 |
May, 2012 | FDA 483 | Northern Biomedical Research, Inc. - Form 483, 2012-05-24 |
July, 2010 | FDA 483 | Charles River Laboratories - Form 483, 2010-07-07 |
March, 2013 | EIR | Eurofins PROXY Laboratories B.V. - EIR, 2013-03-18 |
May, 2012 | EIR | Northern Biomedical Research, Inc. - EIR, 2012-05-24 |
July, 2010 | EIR | Charles River Laboratories - EIR, 2010-07-07 |
April, 2013 | EIR | Almac Pharma Services Limited - EIR, 2013-04-26 |
May, 2012 | FDA 483 Response | Northern Biomedical Research, Inc. - Form 483R, 2012-06-07 |
June, 2022 | FDA 483 | Midwestern Pet Foods, Inc. - Form 483, 2022-06-22 |
March, 2013 | FDA 483 | Eurofins PROXY Laboratories B.V. - Form 483, 2013-03-18 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more